Treatment · April 21, 2026
FDA Clears Investigational Drug for Chemotherapy Pain and Neuropathy
Dogwood Therapeutics receives FDA approval to advance its SP16 cancer program, moving closer to potential patient treatment....
Mental Health · April 20, 2026
Virginia Prepares for Medical Psilocybin Use Following Anticipated FDA Approval
New legislation advances FDA-approved psilocybin treatment option for patients in need....
Mental Health · April 19, 2026
Federal Initiative Fast Tracks Psychedelic Therapies for Mental Health Conditions
Executive order expedites FDA review of psychedelics for treating mental health disorders....
Treatment · April 19, 2026
Four Novel Therapies Approach FDA Approval Offering New Hope for Chronic Conditions
Four promising new drugs entering treatment options this spring could significantly transform patient care across multiple conditi...
Cancer · April 13, 2026
FDA Clears First Cancer Drug for Human Trials Using Only Human Organoid Data
FDA approves new cancer drug for trials using innovative nonanimal data, marking progress in both treatment and ethical research....
Cancer · April 13, 2026
FDA Caps Year With Wave of New Cancer Drug Approvals and Expanded Options
Multiple new oncology drugs received FDA approval, expanding treatment options for cancer patients....
Treatment · April 10, 2026
FDA Clears Novel Switchable CAR-T Therapy Trial for Major Autoimmune Diseases
FDA clears testing of innovative CAR-T therapy for autoimmune diseases, opening new therapeutic possibilities....
Mental Health · April 6, 2026
Bipartisan Bill Directs VA to Prepare for Future Psychedelic Therapies
New VA law prepares to implement FDA-approved psychedelic treatments for veterans....
Treatment · April 3, 2026
FDA Approves First Convenient Daily Pill for Weight Loss Without Meal Restrictions
FDA approval of a new oral GLP-1 pill offers patients another accessible weight loss treatment....
Treatment · April 1, 2026
FDA Approves New Daily Pill for Weight Management as Second Oral GLP-1 Option
Eli Lilly's new weight-loss pill receives FDA approval, offering patients an additional therapeutic option for obesity management....
Treatment · April 1, 2026
FDA Approves New Oral Weight Loss Drug Foundayo as Market Expands
FDA approval of Eli Lilly's GLP-1 pill provides patients with a new oral option for effective weight loss treatment....
Breakthrough · March 30, 2026
FDA Approves First Disease Modifying Therapy for Progressive Multiple Sclerosis
FDA made impactful decisions in neurology that advance patient treatment options....
Breakthrough · March 29, 2026
FDA Shifts Drug Approval Standard to Single Clinical Trial for Most New Medicines
FDA's removal of dual-study requirement expedites drug approvals and speeds life-saving treatments to patients....
Research · March 27, 2026
Drug Trial Success Rates Show Signs of Recovery After Decades of Decline
Analysis of clinical trial success rates in the 21st century provides insights for improving drug development and approval process...
Treatment · March 26, 2026
FDA Approves First Therapy for Ultra Rare Rapid Aging Disease Progeria
February FDA developments including kinase inhibitors, GLP-1 treatments, and new approval pathways represent important therapeutic...
Cancer · March 25, 2026
FDA Approves New Standard of Care for Head and Neck Cancer After Two Decades
FDA approvals in oncology during April-June 2025 bring new treatment options to cancer patients....
Treatment · March 25, 2026
US Health Authorities Continue Compassionate Access to Monkeypox Drug Tecovirimat
FDA-approved Tecovirimat provides an effective treatment option for monkeypox infections....
Treatment · March 25, 2026
FDA Approves Higher Dose Wegovy Offering Greater Average Weight Loss
New higher-dose Wegovy option gives patients more flexibility in managing their weight and health....
Breakthrough · March 24, 2026
FDA Approves First AI-Directed Cancer Therapy and Streamlines Drug Development Paths
FDA actions in 2026 are reshaping drug development to accelerate the pathway for new treatments to reach patients....
Cancer · March 23, 2026
New FDA Guidance Accelerates Myeloma Drug Approvals and Patient Access
Researchers achieve significant progress in developing new myeloma treatments....
Treatment · March 22, 2026
FDA Approves Higher-Dose Semaglutide for Weight Management Following Accelerated Review
Higher-dose semaglutide receives FDA approval through accelerated review, expanding treatment options....
Pediatrics · March 21, 2026
New Drug Awaits FDA Decision Offering Hope for Children With Fatal Hunter Syndrome
A mother's urgent advocacy for FDA approval of a new drug offers hope for children suffering from terminal Hunter Syndrome....
Technology · February 23, 2026
FDA Streamlines Approval Process to Accelerate Gene Therapy Access
FDA streamlines approval process for gene therapies, accelerating life-saving treatments to patients....
Treatment · February 23, 2026
FDA Unveils Plan To Speed Approval Of Rare Disease Treatments
FDA announces plans to accelerate approval timelines for rare disease treatments, benefiting patients in need....
Mental Health · February 20, 2026
FDA Approves New Drug for Bipolar Disorder and Schizophrenia
FDA approval of new bipolar disorder and schizophrenia treatment offers patients an additional therapeutic option....
Breakthrough · February 19, 2026
FDA To Allow Single-Study Drug Approvals In Bid To Speed New Treatments
FDA streamlines drug approval process with single-study requirement, potentially bringing life-saving treatments to patients faste...
Cancer · February 17, 2026
FDA Approves First New Treatment for Advanced Pancreatic Cancer in Years
The FDA has approved a new treatment option for patients with locally advanced pancreatic cancer, offering additional hope....
Cancer · January 2, 2026
FDA Approves Six Novel Cancer Therapies In Landmark Month For Oncology
Six new cancer therapies approved by FDA in December 2025, expanding hope for cancer patients....
Treatment · December 31, 2025
Key FDA Approvals of 2025 Signal Major Shifts in Patient Treatment
Top FDA approvals of 2025 highlight significant advances in pharmaceutical innovation and patient care....
Cancer · December 15, 2025
New Cancer Drugs Approved in 2025 After Pivotal Clinical Trial Results
Multiple new cancer drugs approved in 2025 from leading cancer research institution offer patients new hope....
Cancer · December 11, 2025
FDA Expands Bladder Cancer Drug Approval to Earlier Treatment Stages
Bladder cancer therapy expands FDA approval, bringing treatment access to more patients....
Pediatrics · December 5, 2025
FDA Approves Spinal Canal Delivery Method for SMA Gene Therapy
FDA approves innovative new delivery method for spinal muscular atrophy gene therapy, improving accessibility for patients....
Breakthrough · December 2, 2025
FDA Grants Priority Review to New Hypertension Drug for Treatment-Resistant Cases
Baxdrostat receives FDA priority review as a promising new option for patients struggling to control hypertension....
Breakthrough · August 18, 2025
FDA Grants Orphan Drug Status for Promising Behçet's Disease Treatment
Soligenix receives orphan drug designation for Behçet's disease treatment, offering hope to patients with this rare condition....